Testing effectiveness (Phase 2)UnknownNCT02152774
What this trial is testing
Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Chronic Angle-closure Glaucoma
Who this might be right for
Chronic Angle-closure Glaucoma
New York Glaucoma Research Institute 10